Jin T. Lim, Ph.D. - Publications

Affiliations: 
2003 Columbia University, New York, NY 
Area:
Molecular Biology, Oncology, Public Health

16 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Rakshit DS, Lim JT, Ly K, Ivashkiv LB, Nestor BJ, Sculco TP, Purdue PE. Involvement of complement receptor 3 (CR3) and scavenger receptor in macrophage responses to wear debris. Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society. 24: 2036-44. PMID 16947312 DOI: 10.1002/jor.20275  0.48
2006 Lim JT, Joe AK, Suzui M, Shimizu M, Masuda M, Weinstein IB. Sulindac sulfide and exisulind inhibit expression of the estrogen and progesterone receptors in human breast cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3478-84. PMID 16740773 DOI: 10.1158/1078-0432.CCR-05-2051  0.48
2005 Shimizu M, Deguchi A, Lim JT, Moriwaki H, Kopelovich L, Weinstein IB. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 2735-46. PMID 15814656 DOI: 10.1158/1078-0432.CCR-04-2014  0.48
2005 Lim JT, Mansukhani M, Weinstein IB. Cyclin-dependent kinase 6 associates with the androgen receptor and enhances its transcriptional activity in prostate cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 102: 5156-61. PMID 15790678 DOI: 10.1073/pnas.0501203102  0.48
2004 Shimizu M, Suzui M, Deguchi A, Lim JT, Xiao D, Hayes JH, Papadopoulos KP, Weinstein IB. Synergistic effects of acyclic retinoid and OSI-461 on growth inhibition and gene expression in human hepatoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 6710-21. PMID 15475462 DOI: 10.1158/1078-0432.CCR-04-0659  0.48
2004 Suzui M, Shimizu M, Masuda M, Lim JT, Yoshimi N, Weinstein IB. Acyclic retinoid activates retinoic acid receptor beta and induces transcriptional activation of p21(CIP1) in HepG2 human hepatoma cells. Molecular Cancer Therapeutics. 3: 309-16. PMID 15026551  0.48
2004 Shimizu M, Suzui M, Deguchi A, Lim JT, Weinstein IB. Effects of acyclic retinoid on growth, cell cycle control, epidermal growth factor receptor signaling, and gene expression in human squamous cell carcinoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 1130-40. PMID 14871993 DOI: 10.1158/1078-0432.CCR-0714-3  0.48
2004 Einbond LS, Shimizu M, Xiao D, Nuntanakorn P, Lim JT, Suzui M, Seter C, Pertel T, Kennelly EJ, Kronenberg F, Weinstein IB. Growth inhibitory activity of extracts and purified components of black cohosh on human breast cancer cells. Breast Cancer Research and Treatment. 83: 221-31. PMID 14758092 DOI: 10.1023/B:BREA.0000014043.56230.a3  0.48
2003 Lim JT, Piazza GA, Pamukcu R, Thompson WJ, Weinstein IB. Exisulind and related compounds inhibit expression and function of the androgen receptor in human prostate cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 4972-82. PMID 14581372  0.48
2003 Masuda M, Suzui M, Lim JT, Weinstein IB. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 9: 3486-91. PMID 12960141  0.48
2002 Masuda M, Suzui M, Lim JT, Deguchi A, Soh JW, Weinstein IB. Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction. Journal of Experimental Therapeutics & Oncology. 2: 350-9. PMID 12440226 DOI: 10.1046/j.1359-4117.2002.01062.x  0.48
2002 Suzui M, Masuda M, Lim JT, Albanese C, Pestell RG, Weinstein IB. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1. Cancer Research. 62: 3997-4006. PMID 12124333  0.48
1999 Lim JT, Piazza GA, Han EK, Delohery TM, Li H, Finn TS, Buttyan R, Yamamoto H, Sperl GJ, Brendel K, Gross PH, Pamukcu R, Weinstein IB. Sulindac derivatives inhibit growth and induce apoptosis in human prostate cancer cell lines. Biochemical Pharmacology. 58: 1097-107. PMID 10484067 DOI: 10.1016/S0006-2952(99)00200-2  0.48
1999 Yamamoto H, Soh JW, Shirin H, Xing WQ, Lim JT, Yao Y, Slosberg E, Tomita N, Schieren I, Weinstein IB. Comparative effects of overexpression of p27Kip1 and p21Cip1/Waf1 on growth and differentiation in human colon carcinoma cells. Oncogene. 18: 103-15. PMID 9926925 DOI: 10.1038/sj.onc.1202269  0.48
1998 Han EK, Arber N, Yamamoto H, Lim JT, Delohery T, Pamukcu R, Piazza GA, Xing WQ, Weinstein IB. Effects of sulindac and its metabolites on growth and apoptosis in human mammary epithelial and breast carcinoma cell lines. Breast Cancer Research and Treatment. 48: 195-203. PMID 9598866 DOI: 10.1023/A:1005924730450  0.48
1998 Han EK, Lim JT, Arber N, Rubin MA, Xing WQ, Weinstein IB. Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors. The Prostate. 35: 95-101. PMID 9568672 DOI: 10.1002/(SICI)1097-0045(19980501)35:2<95::AID-PROS2>3.0.CO;2-F  0.48
Show low-probability matches.